On March 29, 2024, the Board of Directors of Cerus Corporation (the “Company”) adopted certain amendments to its Code of Business Conduct and Ethics the (“Code”) as part of its ordinary course recurrent review of the Company’s corporate governance policies. The amendments:
- update the Company’s policies and procedures with respect to (i) legal and regulatory compliance, including trade sanctions, anti-trust regulations, interactions with healthcare professionals and maintenance of books and records, (ii) relationships that create actual or potential conflicts of interest and (iii) confidentiality;
- update and expand the description of the Company’s compliance program; and
- make various other updates, including clarifying, ministerial and conforming changes.
The adoption of the amendments did not result in any explicit or implicit waiver of any provision of the Code as in effect prior to the adoption of these amendments. The foregoing description of the amendments to the Code does not purport to be complete and is qualified in its entirety by reference to the full text of the Code, as amended, a copy of which is available at the link provided below.